Delhi most unsafe for women travellers

March 6, 2014

Delhi__unsafeNew Delhi, Mar 6: Delhi has been pegged as the most unsafe city in the country, for the second time in a row, by women travellers, a recent survey has found.

"Delhi retained its notorious reputation as the most unsafe city amongst the top 10 Indian cities polled with 95 per cent respondents expressing the opinion as opposed to 84 per cent in 2013" according to a survey by travel portal Trip Advisor.

Kolkata and Jaipur were ranked second and third most unsafe cities respectively with 64 per cent and 53 per cent votes each.

Ahmedabad toppled Mumbai to be rated the safest city by 85 per cent of respondents even as Maharashtra and Gujarat were voted to be the safest states with 16 and 14 per cent votes each. Mumbai (72 per cent) dropped to the 5th spot this year from the number 1 position in 2013.

The survey also noted that it was surprising to find that only 16 per cent women use the women safety applications that are available.

"Whether travelling alone or in a group of women, majority of respondents preferred travelling to a city as it offered a higher sense of security, law and order. Hill stations and beaches were second and third choice respectively," the annual women traveller survey 2014 by the travel portal said.

The findings which come ahead of the International Women's day are based on information collected from 1068 women and are aimed at at understanding travel sentiment and preferences of Indian women with respect to leisure travel while travelling solo or as part of an all-women group.

47 per cent of the respondents said they took leisure trips as part of a group of women compared to 35 per cent who travelled solo in the last two years.

"43 per cent of respondents were between the age of 18 and 35 years and 27 per cent of them fell into the category between 35 to 45 years," Nikhil Ganju, Country Manager, TripAdvisor said.

Ganju said there seemed to an rising trend of women who travelled solo or in womens only groups.

Out of 37 per cent respondents who have travelled solo, 56 per cent said they liked travelling alone and will continue to do so in the future.

A total of 53 per cent said they travel alone only to destinations (India or abroad) that are perceived as "safe."

"Solo women travellers preferred yoga and other spiritual retreats three times over to those travelling in a group who preferred to do activities like sightseeing and shopping," Ganju said.

For solo travellers other preferred activities include festivals of music or literature (29 per cent), health or wellness (24 per cent) as well as light adventure like camping and hiking (23 per cent).

For women travelling as a group preferred activities include Sightseeing-Eco tours or village tours (28 per cent), light adventure-camping, hiking (39 per cent), festivals of music or literature (20 per cent) and cruise or house boat (20 per cent).

The respondents included a mix of working professionals self employed women as well as homemakers.

Comments

Add new comment

  • Coastaldigest.com reserves the right to delete or block any comments.
  • Coastaldigset.com is not responsible for its readers’ comments.
  • Comments that are abusive, incendiary or irrelevant are strictly prohibited.
  • Please use a genuine email ID and provide your name to avoid reject.
News Network
March 30,2020

New Delhi, Mar 30: The number of COVID-19 cases climbed to 1,071 in India on Monday, while the death toll rose to 29, according to the Union Health Ministry.

The number of active COVID-19 cases stood at 942, while 99 people were either cured or discharged and one had migrated, the ministry stated.

In its updated data at 10.30 am, it said two fresh deaths were reported from Maharashtra.

Thus, Maharashtra has reported the maximum number of eight COVID-19 deaths so far, followed by Gujarat (5), Karnataka (3), Madhya Pradesh (2), Delhi (2) and Jammu and Kashmir (2).

Kerala, Telangana, Tamil Nadu, Bihar, West Bengal, Punjab and Himachal Pradesh have reported a death each.

The total number of 1,071 cases includes 49 foreigners.

The highest number of confirmed cases of the pandemic has been reported from Kerala (194) so far, followed by Maharashtra at 193.

The number of cases has gone up to 80 in Karnataka, while Uttar Pradesh has reported 75 cases.

The number of cases has risen to 69 in Telangana, 58 in Gujarat and 57 in Rajasthan.

Delhi has reported 53 cases, while in Tamil Nadu, the number of positive cases is 50.

Punjab has reported 38 cases, while 33 COVID-19 cases have been detected each in Haryana and Madhya Pradesh.

There are 31 cases of the contagion in Jammu and Kashmir, followed by Andhra Pradesh (19), West Bengal (19) and Ladakh (13).

Bihar has 11 cases, while nine cases have been reported from the Andaman and Nicobar Islands. Chandigarh has eight cases, while Chhattisgarh and Uttarakhand have reported seven cases each.

Goa has reported five coronavirus cases, while Himachal Pradesh and Odisha have reported three cases each. Puducherry, Mizoram and Manipur have reported a case each, the Health Ministry said.

Comments

Add new comment

  • Coastaldigest.com reserves the right to delete or block any comments.
  • Coastaldigset.com is not responsible for its readers’ comments.
  • Comments that are abusive, incendiary or irrelevant are strictly prohibited.
  • Please use a genuine email ID and provide your name to avoid reject.
Agencies
February 11,2020

New Delhi, Feb 11: Senior Delhi Congress leader and national spokesperson of the party Sharmishtha Mukherjee alleged delay in decision making and lack of strategy and unity at the state level for the party's humiliating performance reflected in the Assembly poll results on Tuesday.

Mukherjee, president of Delhi Mahila Congress, stated that it was high time that the party takes some action. She added that she too was responsible for the Congress' poor show.

The Congress is on the verge of drawing blank again in the Assembly polls as all its candidates were way far behind their AAP and BJP opponents on all the 70 seats. In the 2015 Assembly elections too, Congress failed to win any seat.

"We r again decimated in Delhi. Enuf of introspection, time 4 action now. Inordinate delay in decision making at the top, lack of strategy & unity at state level, demotivated workers, no grassroots connect-all r factors. Being part of d system, I too take my share of responsibility (sic)," Mukherjee tweeted as the results came out.

She also accused the BJP of playing divisive politics while crediting Delhi Chief Minister Arvind Kejriwal for playing "smart politics" as the results showed a clean sweep by the AAP to return to power.

"BJP playing divisive politics, Kejriwal playing ‘smart politics’ & what r we doing? Can we honestly say that we’ve done all 2 put our house in order? We r busy capturing Congress whereas other parties are capturing India. If we r 2 survive, time 2 come out of exalted echo chambers! (sic)," she said in another tweet.

The Congress contested the Delhi polls in alliance with the Rashtriya Janta Dal (RJD), fielding candidates on 66 seats and leaving four to its partner.

Comments

Add new comment

  • Coastaldigest.com reserves the right to delete or block any comments.
  • Coastaldigset.com is not responsible for its readers’ comments.
  • Comments that are abusive, incendiary or irrelevant are strictly prohibited.
  • Please use a genuine email ID and provide your name to avoid reject.
News Network
April 30,2020

Bengaluru, Apr 30: Shares of Glenmark Pharmaceuticals Ltd rose almost 9% on Thursday after the Indian drugmaker got an approval to conduct clinical trials with antiviral drug favipiravir, seen as a potential treatment for COVID-19.

Favipiravir, manufactured under the brand name Avigan by a unit of Japan's Fujifilm Holdings Corp and approved for use as an anti-flu drug in the Asian island country in 2014, has been effective, with no obvious side-effects, in helping coronavirus patients recover, a Chinese official told reporters at a news conference last month.

"After having successfully developed the API and the formulations ... Glenmark is all geared to immediately begin clinical trials on favipiravir on COVID-19 patients in India," Sushrut Kulkarni, executive vice-president for Global R&D, Glenmark Pharmaceuticals, said in a statement. 

The Drug Controller General of India, the country's drug regulator, did not immediately respond to Reuters request for comment.

On Wednesday, another Indian pharmaceutical company, Strides Pharma Science Ltd, said it had developed and commercialized favipiravir antiviral tablets, and had applied to Indian drug authorities to start trials.

Shares of Mumbai-based Glenmark Pharmaceuticals, which rose as much as 8.9% to 359 rupees ($4.78), was trading up 5.9%, as of 0407 GMT.

Comments

Add new comment

  • Coastaldigest.com reserves the right to delete or block any comments.
  • Coastaldigset.com is not responsible for its readers’ comments.
  • Comments that are abusive, incendiary or irrelevant are strictly prohibited.
  • Please use a genuine email ID and provide your name to avoid reject.